Development of eosinophilic fasciitis during treatment with certolizumab pegol for ankylosing spondylitis.
Development of eosinophilic fasciitis during treatment with certolizumab pegol for ankylosing spondylitis.
Clin Exp Rheumatol. 2020 Apr 03;
Authors: Debusschere C, De Schepper S, Piette Y, Vanhaecke A, Verbist C, Smith V
PMID: 32242807 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Rheumatology - Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research
More News: Ankylosing Spondylitis | Rheumatology